SAN DIEGO & SEOUL, South Korea--(BUSINESS WIRE)-- #CancerGenome--Inocras, a bioinformatics-led company harnessing the power of whole-genome data and proprietary analytics to deliver curated insights, today announced that new real-world evidence evaluating whole-genome sequencing-based homologous recombination deficiency phenotyping has been accepted for online publication at the 2026 American Society of Clinical Oncology Annual Meeting. The abstract, titled “Whole-genome HRD phenotyping as a pre